fda glp-1 compounding crackdown news october 2025 Compounded weight-loss and hormone drugs are booming, but experts say regulators have little visibility into who is taking them or what side effects they may be causing. ⁠ ⁠ Critics warn that FDA Warns on Certain Forms

However, clinicians may use other approved methods in certain cases

The Precision Peptide Genetic Test screens variants like GLP1R rs6923761, which can support a more personalized conversation with your provider about dosing strategy and expected metabolic response

HDL (good) cholesterol may also improve as weight decreases, creating a more favorable overall lipid profile

Individuals who meet the criteria for Semaglutide GLP-1 treatment, such as having a body mass index (BMI) of 27 or higher and at least one weight-related medical condition, may be prescribed Semaglutide GLP-1 by their healthcare provider

Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide

M., Rosenstock, J., Tran, M